Tag: Hematologic
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader...
– CFT7455 Demonstrated High Cereblon Binding Affinity and Rapid, Deep IKZF1/3 Degradation Enabling Activity across a Panel of Multiple Myeloma Cell Lines Including...